Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10003792349
Persistent link: https://www.econbiz.de/10003852323
Persistent link: https://www.econbiz.de/10001905007
Persistent link: https://www.econbiz.de/10011981115
Persistent link: https://www.econbiz.de/10011983981
Persistent link: https://www.econbiz.de/10012112734
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and a mix of Minimum Efficacy Standards and Price Controls mechanisms (MES PC). Through a...
Persistent link: https://www.econbiz.de/10013114471
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to “elite...
Persistent link: https://www.econbiz.de/10012893126
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012768128
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to "elite capture"...
Persistent link: https://www.econbiz.de/10012479496